Search results
This is a collaboration between the British Society of Gastroenterology (BSG) and the European Society of Gastrointestinal Endoscopy (ESGE), and is a scheduled update of their 2016 guideline on endoscopy in patients on antiplatelet or anticoagulant therapy.
This is a collaboration between the British Society of Gas-troenterology (BSG) and the European Society of Gastroin-testinal Endoscopy (ESGE), and is a scheduled update of their 2016 guideline on endoscopy in patients on antiplate-let or anticoagulant therapy.
the British Society of Gastroenterology (BSG) Endoscopy Committee with input from major stakeholders, to provide a detailed update, incorporating recent advances in sedation for gastrointestinal endoscopy. This guideline covers aspects from pre-assessment of the elective ’well’ patient to patients with significant
Management of antiplatelet therapy and direct oral anticoagulants (DOACs) in acute gastrointestinal haemorrhage is discussed in detail in European Society of Gastrointestinal Endoscopy (ESGE)
The following Guidelines have been endorsed by BSG Oesophageal and Endoscopy Section Committees and replaces the BSG Guideline of 2015. Search BSG's database for Gastroenterology and Endoscopy Guidelines, Journals, Care Bundles, and other clinical resources.
The British Society of Gastroenterology (BSG) endoscopy committee agreed to create a guideline to provide statements and recommendations on the prevalence, risks, diagnosis, treatment, surveillance and screening of gastric premalignant and early gastric malignant lesions.
ESGE recommends device-assisted enteroscopy with small-bowel biopsy in patients with noncontributory ileocolonoscopy and with suspicion of Crohn’s disease on small-bowel cross-sectional ima-ging modalities or small-bowel capsule endoscopy.
